Clostridium difficile 027 infection in Central Italy

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Di Bella, Stefano ^a   Paglia, Maria Grazia ^a   Johnson, Emma ^b   Petrosillo, Nicola ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

027; CDAD; Clostridium difficile; Italy; NAP1

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL STUDY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE 027; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG EXPOSURE; ENTERITIS; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FECES ANALYSIS; FEMALE; HEALTH CARE FACILITY; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; ITALY; LABORATORY DIAGNOSIS; LONG TERM CARE; MALE; MEDICAL HISTORY; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; RECURRENT DISEASE; RELAPSE; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; ITALY; MALE; MIDDLE AGED;

EID: 84871398235     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-370     Document Type: Article

References (34)

1. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S12-S18.
2. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008, 359:1932-1940. 10.1056/NEJMra0707500, 18971494.
3. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: a comprehensive review. Crit Rev Microbiol 2011, 37:178-187. 10.3109/1040841X.2011.556598, 21609252.
4. Kuijper EJ, Coignard B, Tüll P, . ESCMID Study Group for Clostridium difficile EU Member States; European Centre for Disease Prevention and Control Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl 6):2-18. ESCMID Study Group for Clostridium difficile EU Member States; European Centre for Disease Prevention and Control.
5. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
6. Office for National Statistics Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06. Health Stat Q 2008, 37:52-56. Office for National Statistics.
7. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, Johnson S, Gerding DN. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441. 10.1056/NEJMoa051590, 16322603.
8. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449. 10.1056/NEJMoa051639, 16322602.
9. Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill 2005, 10:E050630.2.
10. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 2011, 31:191-196. 10.3343/kjlm.2011.31.3.191, 3129351, 21779194.
11. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194-201. 10.1086/649213, 20025526.
12. Labbé AC, Poirier L, Maccannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008, 52:3180-3187. 10.1128/AAC.00146-08, 2533448, 18573937.
13. Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I, . European Study Group on Clostridium difficile (ESGCD) Prospective study of Clostridium difficile infections in Europe with phenotypic genotypic characterization of the isolates. Clin Microbiol Infect 2007, 13:1048-1057. 10.1111/j.1469-0691.2007.01824.x, 17850341, European Study Group on Clostridium difficile (ESGCD).
14. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084. 10.1016/S0140-6736(05)67420-X, 16182895.
15. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011, 365:1693-1703. 10.1056/NEJMoa1012413, 22047560.
16. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, . ECDIS Study Group Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73. 10.1016/S0140-6736(10)61266-4, 21084111, ECDIS Study Group.
17. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol 2010, 48:2892-2896. 10.1128/JCM.02482-09, 2916588, 20554809.
18. Baldan R, Cavallerio P, Tuscano A, Parlato C, Fossati L, Moro M, Serra R, Cirillo DM. First report of hypervirulent strain polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 2010, 50:126-127. 10.1086/649011, 20001530.
19. Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, Shuptar S, Kamboj M, Kiehn TE. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010, 48:4519-4524. 10.1128/JCM.01648-10, 3008447, 20943860.
20. Bauer MP, Kuijper EJ, van Dissel JT, . European Society of Clinical Microbiology and Infectious Diseases European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079. 10.1111/j.1469-0691.2009.03099.x, 19929973, European Society of Clinical Microbiology and Infectious Diseases.
21. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, . Society for Healthcare Epidemiology of America; Infectious Diseases Society of America Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455. 10.1086/651706, 20307191, Society for Healthcare Epidemiology of America; Infectious Diseases Society of America.
22. Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005, 5:549-557. 10.1016/S1473-3099(05)70215-2, 16122678.
23. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec. Canada. Clin Infect Dis 2005, 40:1591-1597.
24. Huang H, Weintraub A, Fang H, Nord CE. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Scand J Infect Dis 2009, 41:158-159. 10.1080/00365540802484836, 18846478.
25. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339-344. 10.1016/j.cgh.2006.12.027, 17368233.
26. Ananthakrishnan AN, McGinley EL, Binion DG. Excess of hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205-210. 10.1136/gut.2007.128231, 17905821.
27. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345-351. 10.1016/j.cgh.2006.12.028, 17368234.
28. Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF, . for the European Crohn's and Colitis Organisation (ECCO) European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2008, 2:1-23. for the European Crohn's and Colitis Organisation (ECCO).
29. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhea. Lancet 2001, 357:189-193. 10.1016/S0140-6736(00)03592-3, 11213096.
30. Warny M, Vaerman JP, Avesani V, Delmée M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994, 62:384-389. 186119, 8300199.
31. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007, 45:992-998. 10.1086/521854, 17879913.
32. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE, . SHEA Long-Term-Care Committee Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002, 23:696-703. 10.1086/501997, 12452300, SHEA Long-Term-Care Committee.
33. Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, van den Hof S, Notermans DW, Kuijper EJ. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007, 45:695-703. 10.1086/520984, 17712752.
34. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS, Babakhani F, Johnson S, Gerding DN. Decreased cure and increased recurrence rate for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012, 55:351-7. 10.1093/cid/cis430, 22523271.